RESTON, Va.—Twenty million nuclear medicine procedures that detect and evaluate heart disease, brain disorders and cancer—and that use radiopharmaceuticals to treat overactive thyroids and some cancers—are performed each year. While health care providers in many facilities do provide patients with adequate information about nuclear medicine procedures, there’s room for improvement, says a study supported by the Centers of Disease Control and Prevention and the Agency for Healthcare Research and Quality that appears in the December Journal of Nuclear Medicine.
